Revolutionizing Stroke Treatment with AI Technology
In an exciting advancement in stroke care, Brainomix has shared significant findings from its innovative Brainomix 360 Stroke platform. This cutting-edge AI imaging tool has demonstrated remarkable results in enhancing endovascular thrombectomy (EVT) rates, a critical procedure for patients suffering from large vessel occlusion strokes. By analyzing data from over 450,000 patients treated across 107 NHS England hospitals over the last five years, the study showcases the substantial impact of AI technology on medical interventions.
Key Outcomes of the Brainomix 360 Stroke Evaluation
The insights from the study, recently published in The Lancet Digital Health, indicate that the Brainomix 360 Stroke platform led to a doubling of EVT rates among participating hospitals. Dr. George Harston, Chief Medical and Innovation Officer at Brainomix, expressed pride in the study's confirmation of AI's role in increasing mechanical thrombectomy and intravenous thrombolysis, thus enhancing patient outcomes.
Significant Benefits of AI in Stroke Care
What makes the findings particularly compelling is their broader implications for hospitals, especially those that may not specialize in stroke care. The AI platform, by streamlining processes, has notably reduced delays in patient treatment, which is vital in emergency situations. This improvement in access to timely care is especially critical in non-specialist hospitals, where most stroke patients initially present. The collaborative effort with NHS England and the Health Innovation Network underscores the transformative potential of integrating AI into clinical practice.
Impact on Patient Triage and Treatment
The study highlights that facilities utilizing Brainomix 360 Stroke experienced a 100% enhancement in EVT rates compared to a 63% rise in other facilities that did not implement the technology. Moreover, individual patients reviewed with AI imaging were statistically more likely to receive timely EVT. The efficient triage led to a reduction in door-in-door-out times, showcasing how AI can improve system-wide operational efficiencies while delivering essential care to patients.
Improved Patient Outcomes
Data from the evaluation noted that patients receiving treatment through AI-supported imaging software exhibited better outcomes, including less severe disabilities upon hospital discharge. This evidence reinforces the critical role of the Brainomix platform in addressing the urgent and complex needs of stroke patients.
About Brainomix 360 Stroke
Brainomix 360 Stroke is recognized as the premier fully automated AI imaging solution, aimed at enhancing acute stroke assessments through all phases of patient care. By employing sophisticated algorithms for various imaging techniques including CT, CTA, CTP, and MRI, Brainomix 360 provides rapid, precise diagnoses. This capability allows healthcare providers to make informed treatment decisions, thereby significantly influencing patient recovery trajectories.
About Brainomix
Established as a spinout from the University of Oxford, Brainomix has revolutionized AI applications in medical imaging. Along with Brainomix 360 Stroke, the company also offers advanced solutions for lung fibrosis through Brainomix 360 e-Lung technology. With a commitment to aiding clinicians globally, Brainomix has extended its footprint to over 20 countries, marking its significance in the realm of healthcare innovation.
Frequently Asked Questions
What is the purpose of the Brainomix 360 Stroke platform?
The Brainomix 360 Stroke platform is designed to enhance the assessment and treatment of acute stroke patients through automated AI imaging, improving diagnosis and treatment timelines.
How does the use of Brainomix 360 Stroke improve patient outcomes?
The platform increases the likelihood of timely endovascular thrombectomy and intravenous thrombolysis, resulting in better clinical outcomes and reduced disability upon discharge.
Which hospitals participated in the study?
The study included data from 107 NHS England hospitals, covering approximately 450,000 patients over five years to assess the real-world impact of the AI imaging software.
What are the implications of the study's findings for stroke treatment?
The findings indicate that integrating AI technology can significantly enhance treatment rates, particularly in non-specialist hospitals where stroke patients are initially treated.
How does Brainomix contribute to the NHS?
Brainomix collaborates with NHS England to provide innovative AI solutions that improve patient care and streamline emergency response protocols in stroke treatment.
